NCT00338624View on ClinicalTrials.gov

An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.

PHASE3CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

June 30, 2005

Conditions
Urination Disorders
Interventions
DRUG

oxybutynin chloride extended release

All Listed Sponsors
lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00338624 - An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms. | Biotech Hunter | Biotech Hunter